<DOC>
	<DOCNO>NCT01976156</DOCNO>
	<brief_summary>The aim project determine dietary supplementation NOPE-EGCG ( PhosphoLeantm , 30mg NOPE+20mg EGCG per capsule ) : - rescue striatal function , - increase adherence diet , - reduce weight-gain diet , - improve performance impulsivity , go/no-go task , negative outcome learning , - shift fat sweet preference overweight/obese human subject double-blind cross-over design .</brief_summary>
	<brief_title>The Gut-brain Axis : Novel Target Treating Behavioral Alterations Obesity</brief_title>
	<detailed_description>In prior study demonstrate inverse relationship body mass index response dorsal striatum ( DS ) consumption palatable milkshake ( Stice et al . 2008 ) . We also show magnitude reduce response predicts weight gain , especially individual carry copy A1 allele taq1A polymorphism ( Stice et al . 2008 ) . Since A1 allele associate reduced striatal D2 receptor ( Jonsson et al . 1999 , Noble 2003 , Noble et al . 1991 , Pohjalainen et al . 1998 , Ritchie et al . 1998 , Thompson et al . 1997 ) , find implicates dopamine system reduce blood oxygen level dependent ( BOLD ) response . Our result also indicate reduce response consequence , rather cause obesity , since gain weight ( Stice et al . 2010 ) , risk obesity ( Stice et al . 2011 ) ( virtue parental obesity ) , associate reduce DS response palatable food . Taken together result indicate increased adiposity associate blunt DS response palatable food may reflect altered dopamine signal . More recently determine reduced DS response overweight obese subject associate increased impulsivity measure Barratt Impulsiveness Scale go no/no-go task ( Babbs et al , In Press ) . Related finding human , preliminary work rodent show exogenous administration N-Acylethanolamines , oleoylethanolamine ( OEA ) normalize high-fat diet induce dopamine decrease DS possibly induce shift preference ( Tellez et al. , In Press ) . Human test OEA supplementation possible base availability dietary supplement contain OEA precursor NOPE-EGCG ( ( PhosphoLEANtm , 100 mg NOPE+50mg EGCG per capsule ) . PhosphoLEAN show enhance adherence dietary advice overweight healthy subject ( Rondanelli et al . 2009 , Mangine et al . 2012 ) . We therefore propose double-blind cross-over study test whether PhosphoLean rescue striatal function , increase adherence diet , reduce weight-gain diet , improve performance impulsivity , go/no-go task , negative outcome learning , shift fat sweet preference overweight/obese human subject .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<criteria>Right hand , English speaking , nonsmoker ( never smoke 2 cigarette per month ) . Subjects Body Mass Index 2535 kg/m2 ( overweight/obese category I ) range . Subjects good health . Subjects able provide letter physician state physical exam past year general good health specifically test normal range thyroid function Hemoglobin 1Ac ( suffer common metabolic disorder ) . In addition intake confirm normal blood pressure , blood sugar electrolyte balance every subject . ) serious unstable medical illness ( e.g. , cancer ) ; b ) past current history alcoholism consistent drug use ; c ) current history major psychiatric illness define Diagnostic Statistical Manual Diploma Social MedicineIV criterion include eat disorder , ) medication affect alertness ( e.g. , barbiturate , benzodiazepine , chloral hydrate , haloperidol , lithium , carbamazepine , phenytoin , etc . ) psychoactive drug antiobesity agent ; e ) history major head trauma loss consciousness ; f ) ongoing pregnancy ; g ) know taste smell dysfunction ; h ) diagnosis diabetes ; ) know food allergy , certain food sensitivity ( lactose ) ; j ) pregnant nursing woman , k ) history metalworking , injury shrapnel metal sliver , major surgery ; l ) history pacemaker neurostimulator implantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>